← All decks

Orthopaedics

Pathophysiology of Diabetes and Charcot Neuroarthropathy

Built from The Surgical Management of the Diabetic Foot and Ankle

What’s inside

9 sections · 104 slides

  1. 01

    Overview

    • Scope of this topic
    • Structure of the topic

    2 slides

  2. 02

    Diabetes Mellitus

    • Diabetes mellitus as a disorder of glucose metabolism
    • Scale of the disease burden
    • Type I and type II diabetes
    • Common endpoint of both diabetes types
    • Chain from hyperglycemia to limb loss

    5 slides

  3. 03

    Charcot Arthropathy

    • Definition of Charcot arthropathy
    • Changing epidemiology of Charcot arthropathy
    • Historical description of the disease
    • Swollen foot in the active stage of Charcot arthropathy
    • Trigger of the disease process
    • Eichenholtz staging of Charcot arthropathy
    • Eichenholtz stage I: acute or developmental phase
    • Distinguishing Charcot arthropathy from infection
    • Eichenholtz stage II: coalescent or quiescent phase
    • Eichenholtz stage III: reconstruction phase
    • Radiographic appearance of the three Eichenholtz stages
    • Disorganised midfoot architecture on a foot radiograph
    • Late complications of Charcot arthropathy
    • Plantar forefoot ulcer in a diabetic foot

    14 slides

  4. 04

    Pathophysiology of Diabetes

    • Musculoskeletal consequences of diabetes
    • Three systems damaged by diabetes
    • Reading the systems table
    • Systems impaired by diabetes and their underlying mechanisms
    • Abbreviations used in the systems table

    5 slides

  5. 05

    The Vascular System

    • Vascular disease in diabetes
    • Consequences of reduced tissue blood flow
    • Normal role of the endothelium
    • Mechanism of endothelial cell dysfunction
    • Action of peroxynitrite on nitric oxide synthesis
    • Vascular smooth muscle dysfunction
    • Consequences of proinflammatory gene activation in vessels
    • Normal action of insulin on coagulation
    • Prothrombotic state in type II diabetes
    • Free fatty acids and the NF-kB pathway
    • Best current theory of coagulation dysfunction

    11 slides

  6. 06

    The Nervous System

    • Diabetic neuropathy
    • Clinical consequences of diabetic neuropathy
    • Mechanisms of peripheral nerve damage
    • Interaction between nerve-damaging mechanisms
    • Oxidative stress in the nervous system
    • Formation of advanced glycation end products
    • Effect of advanced glycation end products on soft tissue
    • The AGE–RAGE–NF-kB feedback loop
    • Consequences of sustained RAGE activation
    • Microvascular neurologic disease
    • Loss of neural blood flow regulation
    • Structural changes in the intraneural vasculature

    12 slides

  7. 07

    The Immune System

    • Immune dysfunction in diabetes
    • Components of the innate immune system
    • Complement system changes in diabetes
    • Chronically elevated proinflammatory cytokines
    • Impaired polymorphonuclear cell chemotaxis
    • Blunted monocyte response to bacterial stimulation
    • Osteoclast formation driven by RANKL and RANK
    • Function of the adaptive immune system
    • Two arms of the adaptive immune response
    • Macrophage dysfunction and vaccine response
    • Glycosylation of immunoglobulin G
    • Experimental evidence for glycosylated IgG inactivation

    12 slides

  8. 08

    Pathophysiology of Charcot Arthropathy

    • The French Theory
    • The neurotraumatic theory
    • The neurovascular or neurotrophic theory
    • Comparison of the two classic theories
    • Modern understanding of the pathogenesis
    • Interaction between diabetes mellitus and Charcot neuroarthropathy
    • Reading the summary diagram
    • Role of pain in a normal injury response
    • Inflammation as the cause of bone destruction
    • Bone mineral density evidence for inflammation
    • Immunohistological evidence for inflammation
    • Activation of RANKL
    • The RANKL–RANK–RAGE axis and osteoclast maturation
    • Osteoclastogenic effect of NF-kB signalling
    • Osteoprotegerin as the physiological brake
    • Mechanism of osteoprotegerin action
    • The RANKL to OPG ratio in Charcot arthropathy
    • Neuropeptides and bone health
    • Calcitonin gene-related peptide
    • Actions of calcitonin gene-related peptide on bone
    • Nitrous oxide as a bone-regulating neuropeptide
    • Combined effect of neuropeptide loss

    22 slides

  9. 09

    Summary

    • Combined clinical challenge
    • Relative contribution of diabetes and neuropathy
    • Where to focus understanding
    • Recurring molecular themes across all three systems
    • Key points to remember
    • References
    • References (continued)
    • References (continued)
    • References (continued)
    • References (continued)
    • References (continued)
    • References (continued)
    • The Surgical Management of the Diabetic Foot and Ankle

    13 slides